159 related articles for article (PubMed ID: 2860656)
1. Clinical activity of GABA agonists in neuroleptic- and L-dopa-induced dyskinesia.
Morselli PL; Fournier V; Bossi L; Musch B
Psychopharmacology Suppl; 1985; 2():128-36. PubMed ID: 2860656
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias.
Ziegler M; Fournier V; Bathien N; Morselli PL; Rondot P
Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682
[TBL] [Abstract][Full Text] [Related]
3. Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.
Lloyd KG; Willigens MT; Goldstein M
Psychopharmacology Suppl; 1985; 2():200-10. PubMed ID: 2987905
[TBL] [Abstract][Full Text] [Related]
4. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Alabed S; Latifeh Y; Mohammad HA; Rifai A
Cochrane Database Syst Rev; 2011 Apr; (4):CD000203. PubMed ID: 21491376
[TBL] [Abstract][Full Text] [Related]
5. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Soares KV; McGrath JJ; Deeks JJ
Cochrane Database Syst Rev; 2001; (2):CD000203. PubMed ID: 11405955
[TBL] [Abstract][Full Text] [Related]
6. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Soares K; Rathbone J; Deeks J
Cochrane Database Syst Rev; 2004 Oct; (4):CD000203. PubMed ID: 15494993
[TBL] [Abstract][Full Text] [Related]
7. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia.
Soares KV; McGrath JJ; Deeks JJ
Cochrane Database Syst Rev; 2000; (2):CD000203. PubMed ID: 10796320
[TBL] [Abstract][Full Text] [Related]
8. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study.
Rondot P; Bathien N
Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446
[No Abstract] [Full Text] [Related]
9. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic measures in tardive dyskinesia].
Tegeler J; Wöller W
Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
[TBL] [Abstract][Full Text] [Related]
11. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
Bathien N; Rondot P; Koutlidis RM
J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
[TBL] [Abstract][Full Text] [Related]
13. Dyskinesia: L-dopa-induced and tardive dyskinesia.
Rascol O; Fabre N
Clin Neuropharmacol; 2001; 24(6):313-23. PubMed ID: 11801806
[TBL] [Abstract][Full Text] [Related]
14. Dopamine, GABA, cholecystokinin and opioids in neuroleptic-induced tardive dyskinesia.
Ebadi M; Hama Y
Neurosci Biobehav Rev; 1988; 12(3-4):179-87. PubMed ID: 2906420
[TBL] [Abstract][Full Text] [Related]
15. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and therapeutic actions of GABA receptor agonists.
Zivkovic B; Scatton B; Worms P; Lloyd KG; Bartholini G
J Neural Transm Suppl; 1983; 18():319-26. PubMed ID: 6308150
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
Jeste DV; Wyatt RJ
Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
[TBL] [Abstract][Full Text] [Related]
18. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
[TBL] [Abstract][Full Text] [Related]
19. Improvement in tardive dyskinesia after muscimol therapy.
Tamminga CA; Crayton JW; Chase TN
Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
[TBL] [Abstract][Full Text] [Related]
20. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
Berger PA; Rexroth K
Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
